Dogs were bled 50 ml./min. until mean systemic pressure approximated 35 mm. Hg. Blood pressure was maintained at this level for 30 min. 1-Norepinephrine was then infused in amounts sufficient to increase systemic blood pressure to twice the shock level or more. Measurements of systemic blood pressure, right atrial and pulmonary arterial pressures and of direct Fick cardiac output were made in the control period, during shock, during norepinephrine infusion, and following discontinuation of norepinephrine. Both cardiac output and peripheral resistance increased during the infusion of norepinephrine.
A /PHOUGH earlier reports by Goldenberg, Pines, Baldwin, Greene and Roh 1 indicated no significant increase of cardiac output in human subjects receiving infusion of 1-norepinephrine, later studies have indicated that this drug has important cardiac action. Garb, 2 using an isolated papillary muscle preparation found that there was more increase in contractile force produced by d-1-norepinephrine than by epinephrine. Gazes, Goldberg and Darby 3 and Cotten and Pincus 4 found that the force of cardiac contraction of the dog, as measured by a strain gage arch sutured to the ventricle, was increased by norepinephrine. Brewster, Isaacs, Osgood and King 5 found an increase in cardiac output following norepinephrine infusion in dogs. Because of the foregoing studies it seems pertinent to investigate the mechanism by which infusion of 1-norepinephrine produces an increase in systemic blood pressure in hemorrhagic shock.
The present study was designed to determine the effect upon cardiac output and peripheral resistance of 1-norepinephrine infusion in dogs with hemorrhagic shock, when the drug is given in dosage large enough to produce a definite elevation in systemic arterial pressure.
METHODS
The studies were performed upon mongrel dogs of both sexes, anesthetized with Nembutal 30 Following determination of control cardiac output and pressures, the animals were bled at a rate of 50 ml./min. until the arterial pressure approximated 35 mm. Hg. Systemic arterial pressure was maintained at this level by subsequent bleeding or addition of blood as necessary for 30 min. In 6 of the S animals the blood pressure was stabilized at shock level for 30 min. without additional bleeding before cardiac output and pressure measurements were determined. After the lapse of 30 min., measurements of cardiac output and pressures were repeated. The dogs then received an infusion of 1-norepincph- 153 Circulation Research, Volume V, March 1957 rine by constant drip into the femoral vein at a rate necessary to increase the mean systemic arterial pressure to twice the shock level or more. After stabilization of the systemic arterial pressure, measurements of cardiac output and pressures were repeated. Norepinephrine infusion was discontinued. The measurements of pressures and cardiac outputs were repeated after a lapse of 10 min. Total peripheral resistance was calculated as the quotient of systemic arterial mean pressure minus right atrial mean pressure divided by cardiac output in ml./sec. This quotient is multiplied by the constant 1,332.
RESULTS
The results are summarized in tables 1 and 2. It may be seen in rhagic shock ranged from 27 to 43 mm. Hg, and from 65 to 149 mm. Hg during norepinephrine infusion. Ten minutes after discontinuation of norepinephrine the mean systemic pressures ranged between 19 and 49 mm. Hg.
The effect of norepinephrine upon the cardiac output of animals in hemorrhagic shock may be seen in Table 2 . Following bleeding, the mean cardiac output declined from 119 ml./Kg./min. to 32.3 ml./Kg./min. During norepinephrine infusion it increased to 60.9 ml./Kg./min. The mean increase of 28.6 ± 5.8 was significant (p < 0.01). Following discontinuation of norepinephrine cardiac outputs declined to 35.8 ml./Kg./min.; the mean decrease of 25.1 ± 5.57 was significant (p < 0.01). The A-V oxygen difference during hemorrhagic shock increased from a control mean of 5.1 cc/100 ml. of blood to 12.6 cc/100 ml. blood (p < 0.001). During norepinephrine infusion the mean decrease of 3.6 ± 0.74 cc. was significant (p < 0.001). Following discontinuation of norepinephrine the mean increase of 1.6 ± 0.45 was significant (7; < 0.01). The heart rate did not change significantly after bleeding. After discontinuing norepinephrine, there was a decrease in heart rate of 14.3/inin. (p < 0.05). Stroke volume ml./beat fell from 10.3 during the control period to 2.6 after bleeding. The mean decrease of 7.7 ± 1.95 was significant (p < 0.01). During norepinephrine infusion the mean increase of 1.8 ± 0.59 was significant (p < 0.02). After the discontinuation of norepinephrine the mean decrease of 1.7 ± 0.39 was significant (p < 0.01). Total peripheral resistance in dyne second/cm~s declined from a mean control of 7,280 to 6,115 after bleeding. The mean decrease of 1,165 ± 663 was not significant (p < 0.2). During norepinephrine infusion total peripheral resistance increased to 9,345; the mean increase of 2,293 ± 810 was significant {p < 0.01). After its discontinuance total peripheral resistance decreased to 6,171; the mean decrease of 3,174 db 729 was significant (p < 0.01). Pulmonary arterial pressure decreased during shock but this was not significant in this series. There was a significant increase in pulmonary arterial pressure during norepinephrine infusion and a significant decline following. Right atrial pressure declined during bleeding but not significantly. It also declined a little during norepinephrine infusion.
Two animals developed respiratory failure during the period of shock. These animals resumed spontaneous respiration following the infusion of norepinephrine; however, no study was made to determine whether or not they would survive.
DISCUSSION'
The foregoing results indicate that the infusion of large doses of 1-norepinephrine increase systemic blood pressure by increases in both the output and total peripheral resistance. The increase in cardiac output was produced by an increase in stroke volume and probably to some extent by an increase in heart rate.
Gilmore, Smythe and Handford 6 found a significant increase in cardiac output and blood pressure during norepinephrine infusion in the early stage of hemorrhagic shock but not in the late stages. They found no significant rise in right atrial mean pressure nor in total peripheral resistance in their studies. These workers used a dye method to measure the cardiac output. Frank, Frank, Jacob, Weizel, Korman and Fine, 7 however, found that norepinephrine infusion did not increase the cardiac output of dogs with hemorrhagic shock when given during the hypovolemic phase or during the post-transfusion rise in blood pressure. They did however, observe an increase in cardiac output during norepinephrine infusion to dogs in hemorrhagic shock when given in the pretransfusion phase of oligemic shock when the chest was open.
The foregoing would lead one to conclude that norepinephrine is capable of increasing the cardiac output of dogs in certain phases of hemorrhagic shock. Previous studies have not settled the mechanism for this increase in cardiac output. Gilmore and co-workers 6 postulated that it may be due to a direct effect of the myocardium or to increased venous return. Frank and co-workers 7 postulated that it may be caused by a direct cardiac effect or to improved coronary flow. However, Lu and Melville 8 found in the isolated rabbit heart that norepinephrine increased the strength of cardiac contraction before increasing coronary flow. Unpublished studies by the authors have shown that 1-norepinephrine is capable of increasing the cardiac output of the acutely failing dilated right heart during induced pulmonary arterial constriction. Unpublished studies of Fowler and Bloom have shown that 1-norepinephrine can increase the strength of contraction of the isolated beating rat heart.
This study does not elucidate the mechanism of the increase in cardiac output produced by 1-norepinephrine nor does it indicate whether or not the infusion of 1-norepinephrine increases the survival rate of dogs shocked by bleeding. SUMMARY Dogs were bled into a state of shock. Mean systemic blood pressure was maintained at approximately 35 mm./Hg for 30 min. 1-Norepinephrine was then infused in amounts sufficient to increase the systemic arterial pressure to twice the shock level or more. Measurements of systemic blood pressure, right atrial and pulmonary arterial pressures, and of Fiek cardiac output were made in the control period, during shock, during norepinephrine infusions and following discontinuation of norepinephrine. The results indicated that the systemic arterial pressure elevation produced by nor-epinephrine infusion was due to both increase in cardiac output and to an increase in total peripheral resistance.
SUMMAKIO IX IXTERLINGUA
Canes esseva subjicite a sanguination usque a statos de choc. Le systemic pression sanguinee medie esseva mantenite a approximativemente 35 mm Hg durante 30 minutas. Alora 1-norepinephrina esseva infundite in quantitates sufficiente pro augmentar le pression arterial systemic a duo vices le nivello in choc o plus. Mesurationes del systemic pression sanguinee, del pressiones dextero-atrial e pulmono-arterial, e del rendimento cardiac (Fick) esseva executate durante le periodo de controlo, in le stato de choc, durante le infusion de 1-norepinephrina, e post le discontinuation del administration de norepinephrina. Le resultatos indicava que le elevation del systemic pression arterial producite per infusiones de norepinephrina esseva causate per un augmento del rendimento cardiac e etiam per un augmento del total resistentia peripheric.
